Last updated on: 5/13/2008 | Author:

Burkhard Hinz, PhD Biography

Director of the Institute of Toxicology and Pharmacology at the University of Rostock
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"

“Cannabinoids, in addition to having palliative benefits in cancer therapy, have been associated with anticarcinogenic effects. Cannabinoids may… offer a therapeutic option in the treatment of highly invasive cancers.”

“Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1”, Journal of the National Cancer Institute, Dec. 25, 2007

Theoretical Expertise Ranking:
Individuals with MDs, PhDs, JDs, or equivalent advanced degrees in fields relevant to medical marijuana. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to medical marijuana issues.
Involvement and Affiliations:
  • Director, Institute of Toxicology and Pharmacology, University of Rostock
  • Former Researcher, Institute for Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nuremberg
  • PhD, school unknown
  • None found